Bacterial superantigen vaccines

Details Bacterial superantigen vaccines Bacterial superantigen vaccines

2008-05-07

2011-11-29

Allen, Marianne P (Department: 1647)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S069100, C435S071100, C435S320100, C435S325000, C435S252300, C435S252330, C536S023100, C536S023700

Reexamination Certificate

active

08067202

ABSTRACT:
The present invention relates to genetically attenuated superantigen toxin vaccines altered such that superantigen attributes are absent, however the superantigen is effectively recognized and an appropriate immune response is produced. The attenuated superantigen toxins are shown to protect animals against challenge with wild type toxin. Methods of producing and using the altered superantigen toxins are described.

REFERENCES:
patent: 6399332 (2002-06-01), Ulrich et al.
patent: 6713284 (2004-03-01), Ulrich et al.
patent: 7087235 (2006-08-01), Ulrich et al.
Papageorgiou et al., Journal of Molecular Biology, 260:553-569, 1996.
Bavari et al., “Engineered Bacterial Superantigen Vaccines”, Vaccines 96, pp. 135-141 (1996).
Bavari et al., “Superantigen Vaccines: A Comparative Study of Genetically Attenuated Receptor-Binding Mutants ofStaphylcoccal enferotoxin A”, J. Infectious Diseases, 1996, 174:338-345.
Hurley et al., “Identification of Class II Major Histocompatibility Complex and T Cell Receptor Binding Sites in the Superantigen Toxic Shock Syndrome Toxin 1”, J. Exp. Med., vol. 181, 2229-2235, Jun. 1995.
Stiles, et al., “Toxicity ofStaphylococcal enterotoxinsPotentiated by Lipopolysaccharide: Major Histocompatibility Complex Class II Molecule Dependency and Cytokine Release”, Infection and Immunity, vol. 61, No. 12, pp. 5333-5338, Dec. 1993.
Dannecker et al. (1994) Activation of human T cells by the superantigenStaphylococcus enterotoxin B: Analysis on a cellular level.Immunobiology190: 116-126.
Gonzalo et al. (1992) Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.Eur. J. Immunol. 22: 1007-1011.
Bavari et al. (1995) Genetically attenuated bacterial superantigen vaccines.J. Cellular BiochemistrySuppl 21A, abstract C2-204 p. 88.
Bavari et al. (1995)Staphylococcal enterotoxin Aand toxin shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.Infection and Immunity63:423-429.
Mahana et al. (1995) A natural mutation of the amino acid residue at position 60 destroysStaphylococcal enterotoxin Amurine T-cell mitogenicity.Infection and Immunity63:2826-2832.
Woody et al. (1998) Differential immune responses toStaphylococcal enterotoxin Bmutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors.J. Infectious Diseases177: 1013-1022
Ulrich, R. G. et al. (1995)Staphylococcal enterotoxins Aand B share a common structural motif for binding class II major histocompatibility complex molecules.Nature Structural Biology2:554-560.
Ulrich, R. G. et al. (1995) Bacterial superantigens in human disease: structure, function and diversity.Trends in Microbiology3: 463-468.

Affiliated with

Also associated with

Rating

Bacterial superantigen vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bacterial superantigen vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacterial superantigen vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4271528